For years, Roche has been increasing medicine production in the United States. That could pay off for the drug maker as ...

The head of Zealand Pharma has called its $5.3bn partnership with Roche to commercialise an obesity drug with fewer ...

Copenhagen, Denmark Saturday, April 26, 2025, 18:00 Hrs [IST] ...

The top 20 biopharmas demonstrated a strong start to 2025, despite ongoing uncertainty surrounding Trump’s tariffs.

Roche is working to mitigate potential impacts from tariffs by moving production of its medicines to the U.S. and petitioning ...

Swiss pharma giant Roche (ROG: SIX) today reported that it achieved sales growth of 6% (7% in francs) to 15.4 billion francs ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

In today's Pharmalittle roundup, we're reading about Roche and Merck struggles with tariffs, NEJM quizzed by U.S. attorney, ...

Global Data has revealed that the Top 20 Global Biopharmaceutical Companies have witnessed a 6 % growth in market ...

But the company is not ruling out future deals, even in its metabolic unit, which recently saw a major partnership with ...

Roche’s Genentech unit and Repertoire Immune Medicines have entered into a partnership worth $765m to discover and develop T ...

Group sales grew by 6% at constant exchange rates; 7% in CHF, driven by high demand for newer medicines and diagnostic solutions. Roche (RHHBY) ...